FibroGen ( NASDAQ:FGEN ) First Quarter 2024 Results Key Financial Results Revenue: US$55.9m (up 55% from 1Q 2023). Net...
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024 FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31. FGEN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]